For the purpose of this chapter, the words set out in this section
shall, unless the context otherwise requires, have the following meanings:
DNA
Deoxyribonucleic acid.
INSTITUTION
Any single individual, group of individuals, partnership,
association, organization, corporation, educational institution or
medical facility.
NIH
The National Institutes of Health of the United States Department
of Health and Human Services.
NIH GUIDELINES
The following:
A.
Guidelines for research involving recombinant DNA molecules
promulgated by the NIH and found at 46 CFR 34463 through 34487, on
July 1, 1981, as may be amended by the NIH.
B.
Recombinant DNA research physical containment recommendations
for large-scale uses of organisms containing recombinant DNA molecules
(NIH large-scale recommendations) promulgated by the NIH and found
at 45 CFR 24968 through 24971, on April 11, 1980, as may be amended
by the NIH.
RECOMBINANT DNA or RECOMBINANT DNA MOLECULES (RDNA)
Either:
A.
Molecules which are constructed outside living cells by joining
natural or synthetic DNA segments to DNA molecules that can replicate
in a living cell; or
B.
DNA molecules which result from the replication of a molecule described in Subsection
A above.
This chapter shall apply to all institutions of the City of
Springfield which experiment with or use RDNA technology.
RDNA use classified by NIH guidelines as requiring a P4 level
of containment shall be prohibited in the City of Springfield.
All use of RDNA by institutions in the City of Springfield shall
be undertaken only in conformity with current and applicable NIH or
by any successor agency.
Each institution in the City of Springfield which experiments
with or uses RDNA technology shall comply with the administrative
practices as set forth in the NIH guidelines, including but not limited
to the following:
A. The establishment of an institutional biosafety committee (IBC) which
shall contain seven members as follows:
(1) The Commissioner of Public Health, who shall serve as Chairman;
(2) The Chairman of the Public Health Council or his/her alternate;
(3) One member of the neighborhood council from the area affected by
the institution (to be selected by the Mayor);
(4) Two members of the institution;
(5) One person not affiliated with the institution, representing the
interests of the community as to health and environment; and
(6) The chairman of the local emergency planning committee.
B. The nonaffiliated representatives on the IBC shall be bound by the
same rules prohibiting use and disclosure of proprietary information
and trade secrets as other members of the IBC.
C. The IBC shall establish a set of rules and administrative procedures
governing its operation in accordance with the NIH guidelines.
D. The provision of safety plans and manuals, which shall be subject
to the approval of the IBC.
E. The provision of proper training and appropriate safeguards and procedures
for minimizing potential environmental and personal exposure.
F. If the institution is engaged in RDNA research at the P3 containment
level, it shall appoint a biological safety officer, who shall be
a member of the IBC.
G. If the institution is engaged in RDNA use on a "large scale" (as
defined in the NIH large-scale recommendations), compliance with all
additional administrative requirements contained in the NIH large-scale
recommendations.
Enforcement of this chapter shall be the duty of the Department
of Public Health of the City of Springfield.